Effect of Beta-adrenergic Blockade on Elevated Arterial Compliance and Low Systemic Vascular Resistance in Cirrhosis

References

• Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994;20:1359–63.
   PubMed Web of Science ®Google Scholar
• Bernardi M, Fornale L, Dimarco C, Trevisani F, Baraldini M, Gasbarrini A, et al. Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics. J Hepatol 1995;22:309–18.
   PubMed Web of Science ®Google Scholar
• Llach J, Ginés P, Arroyo V, Rimola A, Titó L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology 1988; 94:482–7.
   PubMed Web of Science ®Google Scholar
• Møller S, Henriksen JH. The systemic circulation in cirrhosis. In: Arroyo V, Gines P, Rodes J, Schrier RW, editors. Ascites and renal dysfunction in liver disease. Malden: Blackwell; 1999. p. 307–29.
   Google Scholar
• de Simone G, Roman MJ, Daniels SR, Mureddu G, Kimball TR, Greco R, et al. Age-related changes in total arterial capacitance from birth to maturity in a normotensive population. Hypertension 1997;29:1213–17.
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Fuglsang S, Bendtsen F, Christensen E, Møller S. Arterial compliance in patients with cirrhosis. High stroke volume/pulse pressure ratio as an index of elevated arterial compliance. Am J Physiol 2001. In press.
   Google Scholar
• Henriksen JH, Møller S, Schifter S, Bendtsen F. Increased arterial compliance in decompensated cirrhosis. J Hepatol 1999;31:712–8.
   PubMed Web of Science ®Google Scholar
• Møller S, Hansen EF, Becker U, Brinch K, Henriksen JH, Bendtsen F. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients. Liver 2000;20:51–9.
   Google Scholar
• Bernard B, Lebrec D, Mathurin P, Opolon P, Poynard T. Beta- adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis. Hepatology 1997;25:63–70.
   Google Scholar
• Lebrec D. Medical decompressive therapy for prophylaxis of rebleeding. Digestion 1998;59:48–9.
   PubMedGoogle Scholar
• Bosch J. Medical treatment of portal hypertension. Digestion 1998;59:547–55.
   PubMedGoogle Scholar
• Svendsen TL, Hartling O, Trap-Jensen J. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers. Eur J Clin Pharmacol 1979;15: 223–8.
   Google Scholar
• Bendtsen F, Henriksen JH, Sørensen TIA. Long-term effects of oral propranolol on splanchnic and systemic haemdynamics in patients with cirrhosis and oesophageal varices. Scand J Gastroenterol 1991;26:933–9.
   Google Scholar
• Bendtsen F, Henriksen JH, Sørensen TIA. Propranolol and haemodynamic response in cirrhosis. J Hepatol 1991;13:144–8.
   PubMedGoogle Scholar
• De Cesaris R, Ranieri G, Filitti V, Andriani A. Large artery compliance in essential hypertension. Effects of calcium antagonism and beta-blocking. Am J Hypertens 1992;5:624–8.
   Google Scholar
• Soma J, Aakhus S, Dahl K, Wideroe TE, Skjaerpe T. Total arterial compliance in ambulatory hypertension during selective beta1-adrenergic receptor blockade and angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol 1999;33: 273–9.
   Google Scholar
• Møller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995;109:1917–25.
   Google Scholar
• Henriksen JH, Winkler W. Hepatic blood flow determination. A comparison of 99-Tc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man. J Hepatol 1987;4:66–70.
   Google Scholar
• Stergiopulos N, Segers P, Westerhof N. Use of pulse pressure method for estimating total arterial compliance in vivo. Am J Physiol 1999;276:H424–8.
   Google Scholar
• Yin FC, Ting CT. Compliance changes in physiological and pathological states. J Hypertens Suppl 1992;10:S31–3.
   Google Scholar
• Moreau R, Lebrec D. Endogenous factors involved in the control of arterial tone in cirrhosis. J Hepatol 1995;22:370–6.
   PubMed Web of Science ®Google Scholar
• Groszmann RJ. Vasodilatation and hyperdynamic circulatory state in chronic liver disease. In: Bosch J, Groszmann RJ, editors. Portal hypertension. Pathophysiology and treatment. Oxford: Blackwell; 1994. p. 17–26.
   Google Scholar
• Henriksen JH, Bendtsen F, Sørensen TIA, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989;97:1506–13.
   PubMed Web of Science ®Google Scholar
• Liang YL, Gatzka CD, Du XJ, Cameron JD, Kingwell BA, Dart AM. Effects of heart rate on arterial compliance in men. Clin Exp Pharmacol Physiol 1999;26:342–6.
   PubMedGoogle Scholar
• Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996;24:451–9.
   PubMed Web of Science ®Google Scholar
• Burroughs AK, Patch D. Primary prevention of bleeding from esophageal varices. N Engl J Med 1999;340:1033–5.
   PubMedGoogle Scholar
• Grace ND. Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know [editorial; comment]. Am J Gastroenterol 2000;95: 1862–4.
   PubMedGoogle Scholar
• Henriksen JH, Bendtsen F, Gerbes AL, Christensen NJ, Ring-Larsen H, Sørensen TIA. Estimated central blood volume in cirrhosis—relationship to sympathetic nervous activity, beta- adrenergic blockade and atrial natriuretic factor. Hepatology 1992;16:1163–70.
   Google Scholar